InvestorsHub Logo
Followers 17
Posts 1755
Boards Moderated 0
Alias Born 11/13/2013

Re: None

Tuesday, 04/21/2020 6:50:26 AM

Tuesday, April 21, 2020 6:50:26 AM

Post# of 424639
This was posted by our Captain on ST:


Pocket Rockets against a generic VASCEPA launch:
1. An “At Risk Launch” in the face of an Appeal loss is very dangerous (treble damages at least).
2. Amarin will probably file an additional patent infringement suit against patent # 8,298,554

Both the half gram and the one-gram capsules have composition patents to insure against oxidation. Have you ever wondered why the VASCEPA caps are so clear while Lovaza and Dietary Supplement caps are yellow? See these references for the 8,298,554 patents:

investor.amarincorp.com/new...

patft.uspto.gov/netacgi/nph...

accessdata.fda.gov/scripts/..
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AMRN News